Lucia Gozzo

Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study

Andrea D. Praticò, Laura Longo, Silvana Mansueto et al. · Current Drug Safety · 2018 · 89 citations

Pharmacy, Pediatrics, Pharmacology +17

The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis

Andrea Navarria, Alessandra Tamburella, Fabio Arturo Iannotti et al. · Pharmacological Research · 2014 · 82 citations

Veterinary Medicine, Neuroscience, Pharmacology +16

How many chronic myeloid leukemia patients who started a frontline second‐generation tyrosine kinase inhibitor have to switch to a second‐line treatment? A retrospective analysis from the monitoring registries of the italian medicines agency (AIFA)

Massimo Breccia, Pier Paolo Olimpieri, Odoardo Maria Olimpieri et al. · Cancer Medicine · 2020 · 40 citations · Full text

Medicine, Oncology, Pharmacology +9

The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß 1-42 oligomers in mice

Gian Marco Leggio, Maria Vincenza Catania, Daniela Puzzo et al. · Pharmacological Research · 2016 · 39 citations

Medicine, Neuroscience, Pharmacology +16

Resveratrol and vascular health: evidence from clinical studies and mechanisms of actions related to its metabolites produced by gut microbiota

Justyna Godos, Giovanni Luca Romano, Lucia Gozzo et al. · Frontiers in Pharmacology · 2024 · 35 citations · Full text

Life Sciences, Nutrition, Nutritional Sciences +17